About: Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov

Attributes	Values
rdf:type	Item
description	klinisch onderzoek (nl) A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov (en)
rdfs:label	Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (en) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (nl) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (ast)
skos:prefLabel	Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (en) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (nl) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (ast)
name	Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (en) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (nl) Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (ast)
instance of	wds:Q58407885-C1972401-F7F4-4FA1-AF11-2BAFF47C78EE
instance of	clinical trial
main subject	wds:Q58407885-91DF6226-D2A2-4D57-B13C-35466CE8FFFD
main subject	cancer immunotherapy
research site	wds:Q58407885-A418A172-DF97-4183-A352-242A96F0D72E wds:Q58407885-AF884D21-4379-4E7B-8379-7C7F49CF6D40 wds:Q58407885-B0AA746F-B5CF-4451-83CC-B3B28026C5C1 wds:Q58407885-D79B69A5-AEC2-405F-8E08-340C25D7BF3C
research site	Curie Institute wd:Q2944818 Jean Perrin Center Institut Paoli-Calmettes
minimum age	wds:Q58407885-3D5E42CE-9A19-447E-88E8-E2B96EAEEAC4
minimum age	18 (xsd:decimal)
medical condition	wds:Q58407885-6E160E1B-BAC6-4506-9D57-32C450C17A93 wds:Q58407885-FD5D1FB5-3045-4640-8CBD-2EC9E3810589
medical condition	breast cancer triple-negative breast neoplasm
study type	wds:Q58407885-24FC8B26-2297-4485-97C3-773F12CA7494
study type	interventional study
ClinicalTrials.gov ID	wds:Q58407885-D1A4EFC1-236F-4B91-9BE1-54C331AA5374
ClinicalTrials.gov ID	NCT03616886
research subject recruitment status	wds:Q58407885-EAF7B566-B4FE-4E1B-BD96-92A7CE76AFC4
research subject recruitment status	recruiting
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58407885

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software